학술논문

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Document Type
Article
Source
In The Lancet 2010 376(9742):687-697
Subject
Primary Research
Articles
Language
ISSN
0140-6736